KRAS and neoplasm: Different subgroups were assessed for risk scores based on age, gender, tumor location, survival status, T-stage, tumor stage, EGFR mutation status and KRAS mutation status, wherein all the subgroups had significant differences except the tumor location and EGFR mutation status subgroups.